Xtandi 40 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FHKU6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,443
Award facts
- Contract value 100% obligated
- $10,442.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,442.51 to DMS Pharmaceutical Group Inc. for 120 tablets of XTANDI 40 MG on January 6, 2026, with a completion date of January 7, 2026. This firm fixed-price delivery order represents a procurement of a branded oncology pharmaceutical product with no set-aside designation, indicating competitive award. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected as the awardee based on its established capabilities and performance within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply comprehensive pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare operations globally. The delivery order exemplifies the routine pharmaceutical procurement activities executed under this strategic contracting vehicle to meet recurring medical supply needs of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FHKU6?
SPE2DR26FHKU6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FHKU6 worth?
The government has obligated $10,443 on SPE2DR26FHKU6.
Is contract SPE2DR26FHKU6 an order under another contract?
Yes. SPE2DR26FHKU6 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKU6 competed?
The extent of competition for SPE2DR26FHKU6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award